Selective Killing of Normal and Neoplastic Human B Cells with Anti-CD 19- and Anti-CD22-Ricin A Chain Immunotoxins

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Cancer Drug Delivery

• Publication date

  1986-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/cdd.1986.3.261PMID 2436739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B Cell/Leukemia Panel Workshop: Summary and Comments

  1986cited by this paper
• The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.

  1986influential reference
• Purification of ricin A1, A2, and B chains and characterization of their toxicity.

  1986cited by this paper
• Characterization of a Human B Lymphocyte-Specific Antigen Defined by Monoclonal Antibodies HD6 and HD39

  1986cited by this paper
• HD37 Monoclonal Antibody: A Useful Reagent for Further Characterization of “Non-T, Non-B” Lymphoid Malignancies

  1986cited by this paper
• Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

  1986cited by this paper
• HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

  1986cited by this paper
• A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.

  1985influential reference
• The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.

  1985cited by this paper
• Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.

  1985cited by this paper
• Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain

  1984cited by this paper
• Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.

  1984cited by this paper
• Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma.

  1984cited by this paper
• Human T Lymphocyte Cell Surface Molecules Defined by the Workshop Monoclonal Antibodies (“T Cell Protocol”)

  1984influential reference
• B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

  1984cited by this paper
• B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

  1983cited by this paper
• Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.

  1983cited by this paper
• Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

  1983cited by this paper
• Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

  1983cited by this paper
• In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

  1982cited by this paper
• Neoplastic B Cells as Targets for Antibody‐Ricin A Chain Immunotoxins

  1982cited by this paper
• Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

  1981cited by this paper
• Lignin and bile acid binding.

  1981cited by this paper
• A monoclonal antibody that identifies human peripheral blood monocytes recognizes the accessory- cells required for mitogen-induced T lymphocyte proliferation.

  1981cited by this paper
• Initial characterization of monoclonal antibodies against human monocytes.

  1980cited by this paper
• Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

  1980cited by this paper
• Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells.

  1979cited by this paper
• The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

  1974cited by this paper
• Statistics With Applications to the Biological and Health Sciences.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

  1968cited by this paper

• Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics

  2022cites this paper
• A reevaluation of CD22 expression in human lung cancer.

  2014cites this paper
• Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

  2014cites this paper
• Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond

  2014cites this paper
• Picking the optimal target for antibody-drug conjugates.

  2013cites this paper
• Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia

  2012cites this paper
• Siglecs as targets for therapy in immune-cell-mediated disease.

  2009cites this paper
• Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia

  2006cites this paper
• Restricted Saporin Immunotoxins : Activity Against B-Cell Lines and Chronic Lymphocytic Leukemia Cells

  2005cites this paper
• Comparative evaluation of two purification methods of anti-CD19-c-myc-His6-Cys scFv.

  2005cites this paper
• Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma.

  2004cites this paper
• immunotoxin against BCL-1 murine B-cell leukemia In vivo efficacy of B 43 ( anti-CD 19 )-pokeweed antiviral protein

  2003cites this paper
• Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro

  2000cites this paper
• Receptor-mediated targeted drug or toxin delivery.

  1998cites this paper
• Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry.

  1996cites this paper
• Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.

  1994cites this paper
• Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human malignant B cells.

  1994cites this paper
• Quantitation of immunogold with an interactive image analysis system. A new, practical approach to antibody-induced modulation, internalization and intracellular transport of surface antigens in viable hematopoietic cells.

  1994cites this paper
• Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.

  1993cites this paper
• In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia

  1992cites this paper
• In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.

  1992cites this paper
• The basic fibroblast growth factor‐saporin mitotoxin acts through the basic fibroblast growth factor receptor

  1991cites this paper
• Monoclonal antibodies to inner ear antigens: I. Antigens expressed by supporting cells of the guinea pig cochlea.

  1991cites this paper
• An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.

  1991cites this paper
• Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.

  1990cites this paper
• Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells.

  1990cites this paper
• Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.

  1990cites this paper
• Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis

  1989cites this paper
• Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.

  1989cites this paper
• Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.

  1989cites this paper
• The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies.

  1989cites this paper
• B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.

  1989cites this paper
• Cancer Therapy

  1989cites this paper
• Experimental Approaches to Tumor Therapy with Monoclonal Antibodies

  1989cites this paper
• Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

  1988cites this paper
• Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.

  1988cites this paper
• Therapeutic strategies with monoclonal antibodies and immunoconjugates.

  1988cites this paper
• Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.

  1988cites this paper
• Functional evaluation of CD19- and CD22-negative variants of B-lymphoid cell lines.

  1988cites this paper
• Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.

  1988cites this paper
• Complement-mediated cytolysis: quantification of B cell surface antigen molecules and role of cell cycle.

  1988cites this paper
• Immunotoxins containing single-chain ribosome-inactivating proteins.

  1988cites this paper
• Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomas

  1988cites this paper